Pharmafile Logo

Peter Impey

- PMLiVE

Eli Lilly’s Inluriyo approved by FDA for breast cancer

The oral drug can be used to treat advanced or metastatic breast cancer

- PMLiVE

FDA accepts supplemental New Drug Application for Pharming’s paediatric immunodeficiency therapy

If approved, the treatment would be the first for children with APDS under 12 years

- PMLiVE

Porterhouse appoints Jennifer Stewart as Medical Director in US

Jennifer brings over a decade of experience working in biopharma

- PMLiVE

What does it mean to improve outcomes for patients with chronic conditions?

‘What constitutes a positive outcome for patients does not always align with the outcomes of interest to researchers’

- PMLiVE

Game On: Medscape Education Golfs for a Cause

Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most impactful charity events benefiting patients living with kidney disease,...

Medscape Education

Overcoming MS graphic

SAY selects MS healthy lifestyle charity for 2025 pro bono programme

SAY Communications has selected Overcoming MS as the recipient of its annual pro bono programme, offering strategic and creative support to launch the charity’s first public awareness campaign.

Say Communications

- PMLiVE

BMS, Takeda and Astex join AI training consortium

The initiative focuses on training AI models to aid in drug discovery and development

- PMLiVE

J&J’s Tremfya approved by FDA for children with plaque psoriasis and psoriatic arthritis

The drug is the first IL-23 inhibitor approved for children from the age of six

- PMLiVE

Smarter strategies for systematic literature reviews

‘Conducting an SLR demands strategic thinking, methodological rigour and therapeutic expertise’

- PMLiVE

Innovation in Action at AAFP FMX 2025

This year, Medscape Education is redefining the live learning experience at AAFP FMX 2025. With 8 groundbreaking, accredited symposia, we are proud to be at the heart of the meeting,...

Medscape Education

- PMLiVE

Pfizer agrees pricing and distribution deal with US government

The agreement enables US patients to access medicines at a discount, in addition to providing Pfizer with relief from US tariffs

- PMLiVE

Amgen commits $650m to US manufacturing expansion

The investment is expected to generate up to 750 new jobs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links